{"DataElement":{"publicId":"14427242","version":"1","preferredName":"Mayo Staging System for AL Amyloidosis Initial Study Registration Stage","preferredDefinition":"A coded response that determines the stage at initial study registration as per the Mayo Staging System for AL Amyloidosis.","longName":"14427237v1.00:14427239v1.00","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"14427237","version":"1","preferredName":"Mayo Staging System for AL Amyloidosis Initial Study Registration","preferredDefinition":"A grading system for cardiac involvement in light chain (AL) amyloidosis. It uses serum levels of cardiac troponins (troponin T or I), brain natriuretic peptide (BNP) or its N-terminal propeptide (NT-ProBNP), and the difference between involved and uninvolved free light chains (dFLC) to assess the degree of cardiac muscle injury.:Preceding all others in time or space or degree._The act of enrolling an individual into a study.","longName":"14427235v1.00:14427236v1.00","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"14427235","version":"1","preferredName":"Mayo Staging System for AL Amyloidosis","preferredDefinition":"A grading system for cardiac involvement in light chain (AL) amyloidosis. It uses serum levels of cardiac troponins (troponin T or I), brain natriuretic peptide (BNP) or its N-terminal propeptide (NT-ProBNP), and the difference between involved and uninvolved free light chains (dFLC) to assess the degree of cardiac muscle injury.","longName":"C200768","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mayo Staging System for AL Amyloidosis","conceptCode":"C200768","definition":"A grading system for cardiac involvement in light chain (AL) amyloidosis. It uses serum levels of cardiac troponins (troponin T or I), brain natriuretic peptide (BNP) or its N-terminal propeptide (NT-ProBNP), and the difference between involved and uninvolved free light chains (dFLC) to assess the degree of cardiac muscle injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0333AE8F-0610-712B-E063-731AD00A196F","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14427236","version":"1","preferredName":"First Study Registration","preferredDefinition":"Preceding all others in time or space or degree._The act of enrolling an individual into a study.","longName":"C25509:C200767","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Study Registration","conceptCode":"C200767","definition":"The act of enrolling an individual into a study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0333AE8F-0611-712B-E063-731AD00A196F","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0333AE8F-0612-712B-E063-731AD00A196F","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-11-01","changeDescription":null,"administrativeNotes":"8/18/23 created for SWOG stratification questions. BF;","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14427239","version":"1","preferredName":"Mayo Staging System Stage","preferredDefinition":"A grading system for cardiac involvement in light chain (AL) amyloidosis. It uses serum levels of cardiac troponins (troponin T or I), brain natriuretic peptide (BNP) or its N-terminal propeptide (NT-ProBNP), and the difference between involved and uninvolved free light chains (dFLC) to assess the degree of cardiac muscle injury._The extent of a cancer in the body.","longName":"14427239v1.00","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":null,"ValueMeaning":{"publicId":"2568402","version":"1","preferredName":"Stage 1","longName":"2568402v1.00","preferredDefinition":"Stage 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D83F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0333E4EF-06D6-7A00-E063-731AD00A1C45","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","deletedIndicator":"No"},{"value":"2","valueDescription":null,"ValueMeaning":{"publicId":"14427240","version":"1","preferredName":"Stage 2-3a","longName":"14427240v1.00","preferredDefinition":"Stage 2-3a","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0333E4EF-06D5-7A00-E063-731AD00A1C45","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0333E4EF-06D7-7A00-E063-731AD00A1C45","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14427238","version":"1","preferredName":"Mayo Staging System for AL Amyloidosis Neoplasm Stage","preferredDefinition":"A grading system for cardiac involvement in light chain (AL) amyloidosis. It uses serum levels of cardiac troponins (troponin T or I), brain natriuretic peptide (BNP) or its N-terminal propeptide (NT-ProBNP), and the difference between involved and uninvolved free light chains (dFLC) to assess the degree of cardiac muscle injury._The extent of a cancer in the body.","longName":"14427238v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mayo Staging System for AL Amyloidosis","conceptCode":"C200768","definition":"A grading system for cardiac involvement in light chain (AL) amyloidosis. It uses serum levels of cardiac troponins (troponin T or I), brain natriuretic peptide (BNP) or its N-terminal propeptide (NT-ProBNP), and the difference between involved and uninvolved free light chains (dFLC) to assess the degree of cardiac muscle injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0333D5E4-DB32-781E-E063-731AD00A250C","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0333D5E4-DB33-781E-E063-731AD00A250C","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-11-01","changeDescription":null,"administrativeNotes":"8/18/23 created for SWOG stratification questions. BF;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Mayo Staging System Stage at Initial Study Registration","url":null,"context":"SWOG"},{"name":"SWOG - 1","type":"Alternate Question Text","description":"What was the European 2015 Modification of the Mayo 2004 Prognostic Staging System at initial study registration?","url":null,"context":"SWOG"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"03341D43-37B8-0200-E063-731AD00AC46C","latestVersionIndicator":"Yes","beginDate":"2023-08-18","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-18","modifiedBy":"FINCHAMB","dateModified":"2023-11-01","changeDescription":null,"administrativeNotes":"8/18/23 Created for SWOG stratification questions.  BF;","unresolvedIssues":null,"deletedIndicator":"No"}}